Blood Cancer

In this episode of Meeting Mic, we bring you pearls and perspectives from the 2024 European Society for Medical Oncology Congress with a focus on leukemia.

In this video, Rosalie Griffin, PhD, discusses the results of a study into point mutations and their correlation with developing blood cancers presented at ESMO Congress 2024.

In this video, Rosalie Griffin, PhD, discusses the results of a study she presented at ESMO Congress 2024, which examined a biomarker that could indicate a person’s risk for developing blood cancer.

Older adults diagnosed with a blood cancer exhibited similar rates of cognitive decline as cancer-free controls, according to study results.

A telephone-administered, positive psychology intervention improved the well-being of patients who underwent hematopoietic stem cell transplantation, according to findings published in Journal of the National Comprehensive Cancer Network.

The socioeconomic status of cell donors may affect outcomes of people with blood cancer who undergo hematopoietic stem cell transplantation, according to retrospective study results.

The Leukemia & Lymphoma Society awarded a research team at Fox Chase Cancer Center a nearly $2.4 million grant to improve clinical trial access for patients, particularly those from underrepresented groups, across the Temple Health system.

A blood biomarker used to identify benign vs. malignant pulmonary nodules displayed “excellent” performance regardless of sex, smoking status, screen detection and nodule size, according to a research letter published in CHEST.

Individuals prescribed the antidiabetes treatment metformin less likely developed a myeloproliferative neoplasm —potentially also reducing a person’s chances for developing certain cancers — according to data published in Blood Advances.